Chemical Structure (Renvela 01)
Renvela Powder, For Suspension
Product Images NDC 58468-0132
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Renvela (NDC 58468-0132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Renvela 02)
Figure 3 (Renvela 03)
This appears to be a representation of clinical trial data related to the medication Sevelamer Hydrochloride, likely for the treatment of serum phosphorus reduction. The chart shows a reduction from baseline in serum phosphorus levels, with percentage of patients and reduction levels indicated. However, the specific values and details necessary to accurately interpret the chart are not legible, making further analysis and description not-available.*
Figure 4 (Renvela 04)
Package Label (Principal Display Panel)
Each tablet of Renvela contains 800 mg of the active ingredient Sevelamer carbonate along with several inactive ingredients. It is essential to store the medication at 25°C and dispense it in a tight container. Renvela is manufactured by Genzyme Ireland Ltd and intended for use as per dosage information provided in the package insert. The medication is available in the USA based on Rx only and is supplied in film-coated tablets. The presented text doesn't provide much information on the product's functionality or details on how to consume Renvela.*
Package Label (Principal Display Panel)
This appears to be a product description for a medication called Renvela. It comes in packets containing 2.4g of sevelamer carbonate for oral suspension and has a citrus flavor. Each container includes 90 packets. The text also includes a reference to Scteumsin N1, but it is not clear what this refers to.*
Package Label (Principal Display Panel)
Renvela is a medication that contains sevelamer carbonate for oral suspension in 0.8g packets. This box contains 90 packets of medication. The text also includes some unreadable characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
